TTM
−$2.48
YoY change
-12.4%
5Y CAGR
—
Peak year (2021)
−$0.36
Latest annual
−$2.19
EPS (Diluted) history chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: −$2.19
EPS (Diluted) growth chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: -12.4%
EPS (Diluted) history table for Alto Neuroscience (ANRO) from 2021 to 2025
| 2025 | −$2.19 | -12.4% | +$0.31 | ||
| 2024 | −$2.50 | +85.2% | −$1.15 | ||
| 2023 | −$1.35 | +25.0% | −$0.27 | ||
| 2022 | −$1.08 | +200.0% | −$0.72 | ||
| 2021 | −$0.36 | — | — |
- 2025−$2.19-12.4%
- 2024−$2.50+85.2%
- 2023−$1.35+25.0%
- 2022−$1.08+200.0%
- 2021−$0.36—
EPS (Diluted) values are taken from Alto Neuroscience's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Alto Neuroscience (ANRO)
According to Alto Neuroscience's latest reported financial statements, the company's current diluted EPS (TTM) is −$2.48. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Alto Neuroscience (ANRO) diluted EPS is −$2.19 – declined 12.4% year-over-year.
2021 marks the peak diluted EPS at −$0.36, with the historical low of −$2.50 recorded in 2024.
Alto Neuroscience EPS (Diluted) by Year
Alto Neuroscience EPS (Diluted) 2025: −$2.19
Alto Neuroscience posted diluted EPS of −$2.19 in 2025, declined 12.4% below 2024.
Alto Neuroscience EPS (Diluted) 2024: −$2.50
In 2024, Alto Neuroscience reported diluted EPS of −$2.50, surged 85.2% from 2023. This figure represents the lowest annual value in the available history.
Alto Neuroscience EPS (Diluted) 2023: −$1.35
Alto Neuroscience diluted EPS in 2023 was −$1.35, grew 25.0% from 2022.
Alto Neuroscience EPS (Diluted) 2022: −$1.08
2022's diluted EPS for Alto Neuroscience came in at −$1.08, surged 200.0% from 2021.
Alto Neuroscience EPS (Diluted) 2021: −$0.36
Alto Neuroscience diluted EPS in 2021 was −$0.36.
See more financial history for Alto Neuroscience (ANRO). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Alto Neuroscience (ANRO), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation